A Phase I Study of CDX-622
NCT06650761
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
85
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Participants
Interventions
DRUG:
CDX-622
DRUG:
Normal Saline
Sponsor
Celldex Therapeutics